↓ Skip to main content

A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to…

Overview of attention for article published in Trials, October 2020
Altmetric Badge

Mentioned by

twitter
23 X users

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
186 Mendeley
Title
A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial
Published in
Trials, October 2020
DOI 10.1186/s13063-020-04746-9
Pubmed ID
Authors

Shin Takayama, Takao Namiki, Takashi Ito, Ryutaro Arita, Hajime Nakae, Seiichi Kobayashi, Tetsuhiro Yoshino, Tomoaki Ishigami, Koichiro Tanaka, Mosaburo Kainuma, Kotaro Nochioka, Airi Takagi, Masaru Mimura, Takuhiro Yamaguchi, Tadashi Ishii

X Demographics

X Demographics

The data shown below were collected from the profiles of 23 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 186 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 186 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 21 11%
Student > Master 19 10%
Other 17 9%
Researcher 17 9%
Lecturer 13 7%
Other 37 20%
Unknown 62 33%
Readers by discipline Count As %
Medicine and Dentistry 45 24%
Nursing and Health Professions 22 12%
Pharmacology, Toxicology and Pharmaceutical Science 9 5%
Psychology 8 4%
Biochemistry, Genetics and Molecular Biology 6 3%
Other 26 14%
Unknown 70 38%